Clarification of the FDA accelerated agnostic approval of pembrolizumab and the opportunities arising from the required confirmatory studies - In reply Journal Article

  

Authors:	Prasad, V.; Kaestner, V.; Mailankody, S.
Article Title:	Clarification of the FDA accelerated agnostic approval of pembrolizumab and the opportunities arising from the required confirmatory studies - In reply
Journal Title:	JAMA Oncology
Volume:	4
Issue:	9
ISSN:	2374-2437
Publisher:	American Medical Association
Date Published:	2018-09-01
Start Page:	1300
End Page:	1301
Language:	English
DOI:	10.1001/jamaoncol.2018.1715
PROVIDER:	scopus
PUBMED:	29978197
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053411864&doi=10.1001%2fjamaoncol.2018.1715&partnerID=40&md5=e38849cdbc4f3aedf8228aa393a89d83
Notes:	Letter -- Export Date: 1 October 2018 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/131743